UKHSA

Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"

Retrieved on: 
Monday, April 8, 2024
Microsoft, PCR, Biotechnology, Information technology, COVID-19, UKHSA, Artificial intelligence, Human, Plant, Animal, Security agency, Vaccine

Seegene has facilitated the rapid and effective isolation of individuals infected with COVID-19 by delivering approximately 350 million diagnostic tests to over 100 countries.

Key Points: 
  • Seegene has facilitated the rapid and effective isolation of individuals infected with COVID-19 by delivering approximately 350 million diagnostic tests to over 100 countries.
  • "We greatly value the visit of UKHSA, a world-leading health security agency, to Seegene," said Dr. Chun.
  • "We will continue to explore ways for contributing to the cooperation between Korea and the UK, including through our SG OneSystemTM business" he added.
  • It involves sharing the company's syndromic quantitative PCR technology and Seegene's Digitalized Development System (SGDDS) with leading companies worldwide.

Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"

Retrieved on: 
Monday, April 8, 2024
Microsoft, PCR, Biotechnology, Information technology, COVID-19, UKHSA, Artificial intelligence, Human, Plant, Animal, Security agency, Vaccine

Seegene has facilitated the rapid and effective isolation of individuals infected with COVID-19 by delivering approximately 350 million diagnostic tests to over 100 countries.

Key Points: 
  • Seegene has facilitated the rapid and effective isolation of individuals infected with COVID-19 by delivering approximately 350 million diagnostic tests to over 100 countries.
  • "We greatly value the visit of UKHSA, a world-leading health security agency, to Seegene," said Dr. Chun.
  • "We will continue to explore ways for contributing to the cooperation between Korea and the UK, including through our SG OneSystemTM business" he added.
  • It involves sharing the company's syndromic quantitative PCR technology and Seegene's Digitalized Development System (SGDDS) with leading companies worldwide.

Measles: it's not just London that's at risk of an outbreak – it's all of the UK

Retrieved on: 
Thursday, July 27, 2023
School, UK Health Security Agency, MMR, Vaccination, Rubella, Deafness, Mumps, Profile, Infection, Diphtheria, Measles, Death, Security agency, Risk, NHS England, WHO, UKHSA, NHS, World, Encephalitis, Virus, Notifiable disease, World Health Organization, Pharmaceutical industry, Vaccine, Pneumonia

The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.

Key Points: 
  • The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.
  • The virus spreads like wildfire among the unvaccinated, as demonstrated recently when seven unvaccinated children at a nursery school in Stoke-on-Trent nursery caught the bug.
  • There are no specific drugs for measles, so treatment is to help relieve symptoms and address complications, such as bacterial infections.
  • This pattern is seen globally, with many countries yet to attain the levels of routine immunisation coverage they had pre-pandemic.
  • For MMR, a national catch-up campaign is under way, and many regions have set up measles-elimination groups.
  • If this work is successful, hopefully the UK will be able to regain its measles-free status.

Measles: how declining vaccination levels in London are threatening herd immunity

Retrieved on: 
Tuesday, July 18, 2023
Vaccine, Infection, UK Health Security Agency, MMR, Human, Vaccination, Disease, Probability, Rubella, Post-2015 Development Agenda, Mumps, Profile, World Health Organization, Immunity, Global health, COVID, Vaccine hesitancy, Measles, Death, School, Hospital, Population, Security agency, Risk, Child, Spectrum, Viral, Mass vaccination, WHO, UKHSA, World, Encephalitis, Pneumonia

For 60 years, measles has been preventable by a widely available vaccine, so why is London facing a potential disaster now?

Key Points: 
  • For 60 years, measles has been preventable by a widely available vaccine, so why is London facing a potential disaster now?
  • This means one infected child can pass on the disease to 12 to 18 other children in a completely susceptible population.
  • The current levels of MMR coverage in England, particularly in London, are well below the 95% threshold.
  • The COVID pandemic has seen vaccination levels drop further, creating a perfect storm of low immunity levels.
  • Estimated immunity levels for different age groups, London and England While only three-quarters of eligible five-year-olds in London have received their second MMR dose, immunity levels are not the same across all age groups.
  • The UKHSA has sought to work out immunity levels in different age groups to better understand the risk of outbreaks.
  • With its consistently low vaccination levels, London is more likely to face an outbreak than the rest of the UK.

Arcturus: what to know about the new COVID variant, omicron XBB.1.16

Retrieved on: 
Wednesday, May 3, 2023
Vaccine, Taste, Smell, XBB.1, UK Health Security Agency, Therapy, Vaccination, SARS-CoV-2, Infection, Fever, World, Immunity, COVID, Cell, Omicron, Cough, Animal, Population, Security agency, XBB, Pet, UKHSA, Conjunctivitis, World Health Organization, Pharmaceutical industry, Arcturus, Kraken

It’s important to note that only a small portion of COVID infections undergo genetic sequencing, so it’s likely there are many more cases of Arcturus.

Key Points: 
  • It’s important to note that only a small portion of COVID infections undergo genetic sequencing, so it’s likely there are many more cases of Arcturus.
  • But the variant has been most dominant in India, which had recorded 61% of global sequences of Arcturus as of mid-April.
  • The country was recording more than 10,000 COVID cases each day with Arcturus making up about two-thirds of all cases.
  • Read more: Another new COVID variant is spreading – here's what we know about omicron BA.4.6
    Where did Arcturus come from?

Global Latent Tuberculosis Infection Detection Market to 2030: Increasing Risk of Developing Active Tuberculosis Infection from LTBI Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 15, 2023
Health, Infectious Diseases, Research, TB, NHS, Risk, USD, Organization, HIV, UKHSA, Tuberculosis, Malaria, Government, Mark R. Dybul, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Diagnosis, QIAGEN, LTBI, Infection, Unitaid, Ageing, Vaccine, Pharmaceutical industry

Ltd

Key Points: 
  • Ltd
    The increased risk of developing active disease from latent tuberculosis infection (LTBI) coupled with the surge in the geriatric population globally is one of the major driving factors for the market growth.
  • In addition, rising awareness about TB detection and various government initiatives for effective diagnosis and screening of tuberculosis infection is another factor contributing to market expansion.
  • The market growth is fueled by the increase in the geriatric population across the globe.
  • Whereas the academic and research institutions segment is expected to exhibit the fastest CAGR during the projected period
    Chapter 3 Latent Tuberculosis Infection Detection Market Variables, Trends, & Scope

LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay

Retrieved on: 
Monday, February 6, 2023
COVID-19, Food, Emergency Use Authorization, COVID, Patient, Union, UK Health Security Agency, Security agency, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Severe acute respiratory syndrome coronavirus 2, Infection, UKHSA, Influenza, Vaccine

LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay receives Emergency Use Authorization from the FDA along with being successfully validated by the UK Health Security Agency (UKHSA) under the Coronavirus Test Device Approvals (CTDA) process.

Key Points: 
  • LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay receives Emergency Use Authorization from the FDA along with being successfully validated by the UK Health Security Agency (UKHSA) under the Coronavirus Test Device Approvals (CTDA) process.
  • This multiplex test utilizes the innovative qSTAR technology allowing for high-throughput, direct amplification, with highly sensitive results on open molecular platforms.
  • LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay adds to LumiraDx’s expanding portfolio of qSTAR molecular solutions for COVID testing.
  • The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete multiplex test allows for the simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2 infections within 20 minutes or less.

Dettol Pro Solutions Shares How to Help Prevent Spread of Strep A Via Proper Cleaning Protocols and Product Selection

Retrieved on: 
Wednesday, January 18, 2023
Retail, Health, Chemicals, Plastics, Infectious Diseases, Home Goods, Manufacturing, Supermarket, Disease, Infection, UK Health Security Agency, Urinary tract infection, Scarlet fever, R, Rapid strep test, UKHSA, Sneeze, Security agency, Invasive, Elbow, Virus, Reckitt, Laboratory, Medicine, Streptococcus pyogenes, Severe acute respiratory syndrome coronavirus 2, Skin, Impetigo, Cough, Bacteria, IGAS, GAS, Water, Group A streptococcal infection, Streptococcus, Hygiene, Multimedia, COVID-19, Vaccine, Tissue paper, Dettol

GAS infections often present as a mild sore throat ('strep throat') and skin/soft tissue infections such as impetigo and cellulitis1.

Key Points: 
  • GAS infections often present as a mild sore throat ('strep throat') and skin/soft tissue infections such as impetigo and cellulitis1.
  • Dettol Pro Solutions, which consists of a team of in-house virologists, microbiologists and medical scientists, was launched in the UK last year.
  • Dettol Pro Solutions’ products are demonstrated to kill 99.9% of bacteria and enveloped viruses including Streptococcus A, Covid-19 and Influenza6.
  • For further information and advice from Dettol Pro Solutions, please visit https://www.reckittpro.co.uk .

Tecan and RevoluGen Enter into Agreement for 96-well Plates for Use in Automated Fire Monkey HMW-DNA Extraction Kits Ideal for Scalable DNA Sequencing

Retrieved on: 
Friday, November 11, 2022
CEO, Health, A200, Reading, R, HMW, Company, SP, NAIP, Automation, SIX Swiss Exchange, CSO, D, Merck Group, GLOBE, Doctor of Philosophy, Research, Security agency, ISIN, USD, Cell, QIB, UK Health Security Agency, CHF, Quadram Institute, OEM, Laboratory, DNA, UKHSA, AMR, Molecular biology, Genomics, Population, Time, Super Mario, Fine chemical, Computer data storage, Antibiotics, Tecan

The two companies started to work together in 2020 to validate an automated DNA extraction workflow, the critical first step in the DNA sequencing workflow.

Key Points: 
  • The two companies started to work together in 2020 to validate an automated DNA extraction workflow, the critical first step in the DNA sequencing workflow.
  • This is a significant issue for the multiplexed sequencing runs routinely used in areas such as antimicrobial resistance surveillance.
  • Our validated Fire Monkey process for automated HMW-DNA extraction will further lower the overall cost of multiplexed sequencing and accelerate the uptake of sequencing in many high-volume dependent applications.
  • The DNA sequencing market is currently predicted to grow from $7bn to some $50bn over the next 10 years.

Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes

Retrieved on: 
Tuesday, April 5, 2022
Biotechnology, Typhoid fever, Oxford Nanopore Technologies, HMW, Research, Abraxis BioScience, CSO, Reading, Technology, GSV, University of East Anglia, Security agency, Population, UK Health Security Agency, Bacteria, East Anglia, Conference, Molecular biology, Health, Gemma, Norfolk and Norwich University Hospitals NHS Foundation Trust, Super Mario, Microbiology, Orientation, Campylobacter, DNA, Merck Group, Gene expression, AMR, Biotechnology and Biological Sciences Research Council, Salmonella enterica subsp. enterica, Survival, Doctor of Philosophy, Genomics, Communication, Food chain, BBSRC, Partnership, Company, Cell, NAIP, Automation, Plant, UKHSA, Food, Biology, Microorganism, Norwich Research Park, R, Antibiotics, Vaccine, Fine chemical, Pharmaceutical industry, Purification, Quadram Institute, Tecan, Salmonella

LONDON, April 5, 2022 /PRNewswire/ -- UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes data presented by scientists from its collaborator the Quadram Institute at this years' Microbiology Society Annual Conference being held in Belfast. The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.

Key Points: 
  • The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.
  • Extraction of long length HMW DNA using RevoluGen's Fire Monkey technology facilitated 48-plex sequencing and the successful generation of complete assemblies for samples with ~30X theoretical coverage.
  • Fire Monkey produces DNA fragments that are not too short and not too long for the long-read sequencing technologies.
  • It also facilitates hybrid sequencing from a single extraction, saving valuable DNA samples as well as reducing time and cost.